Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04598321
Title BrUOG 390: Neoadjuvant Treatment With Talazoparib
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Don Dizon
Indications

ovary epithelial cancer

fallopian tube endometrioid adenocarcinoma

peritoneal serous adenocarcinoma

endometrioid ovary carcinoma

ovary serous adenocarcinoma

fallopian tube serous adenocarcinoma

peritoneum cancer

fallopian tube cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.